The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

According to The Business Research Company’s Non-Alcoholic Steatohepatitis (NASH) Global Market Report 2023, the non-alcoholic steatohepatitis (NASH) market is expected to show promising growth in the forecast period.

The global non-alcoholic steatohepatitis (NASH) market is on a robust growth trajectory, expected to surge from $2.42 billion in 2022 to $3.25 billion in 2023, with an impressive compound annual growth rate (CAGR) of 34.5%. Anticipating further expansion, the market size is projected to reach $10.73 billion in 2027, sustaining a compelling CAGR of 34.7%. Let’s delve into the driving forces, key players, and emerging trends shaping the future of the NASH market.

**1. Obesity Epidemic: Catalyst for NASH Market Growth

• The demand for NASH treatment is soaring, propelled by the rising cases of obesity globally.
• Obesity, characterized by abnormal or excessive fat accumulation, is a significant health concern and a key contributor to nonalcoholic fatty liver disease (NAFLD), leading to the widespread prevalence of NASH.
• According to the World Obesity Federation, over 60% of the US population was overweight in 2021, and by 2025, obesity percentages are expected to reach 44.2% for males and 44.4% for females.

**2. Market Leaders: Paving the Way for NASH Treatment

• Major players influencing the NASH market include AstraZeneca plc., Arena Pharmaceuticals Inc., GSK plc., Novo Nordisk A/S, and others.
• These industry giants contribute to the market’s diversity, offering a range of products to address NASH, a potential widespread cause of severe liver disease in the coming decades.
• Their focus extends to various types of NASH treatments, considering both solid and liquid forms.

**3. Technological Advancement: A Key Trend in NASH Market

• Technological innovation stands out as a key trend in the non-alcoholic steatohepatitis (NASH) market.
• Companies are investing in advanced diagnostic solutions to enhance NASH detection. GENFIT Inc., for instance, launched NASHnext, a non-invasive test powered by the NIS4TM screening technology, providing a revolutionary blood-based molecular biomarker test for NASH diagnosis.
• This technological push signifies the commitment of major players to stay at the forefront of NASH diagnostics.

**4. Segmentation Insights: Navigating the Diverse Offerings

• The NASH market is segmented by type, including solid and liquid forms, offering flexibility in treatment options.
• Product categories encompass Vitamin E and Pioglitazone, Ocaliva, Elafibranor, Selonsertib and Cenicriviroc, and other products, catering to diverse patient needs.
• Disease causes such as hypertension, heart disease, high blood lipids, type 2 diabetes, and obesity guide treatment strategies and solutions.

**5. Sales Channels and Applications: Tailoring Access to NASH Treatments

• The market is further classified based on sales channels, with hospital pharmacy, retail pharmacy, and online providers playing pivotal roles in NASH treatment access.
• Applications span oral and parenteral routes, providing flexibility in administering NASH treatments based on patient preferences and needs.

**6. Regional Dynamics: North America Takes the Lead

• North America emerged as the largest region in the NASH market share in 2022, reflecting the region’s robust healthcare infrastructure and rising obesity rates.
• As the market expands, other regions, particularly Asia-Pacific, are expected to witness accelerated growth, driven by increasing healthcare awareness and evolving healthcare infrastructures.

View More On The Non-Alcoholic Steatohepatitis (NASH) Market Report 2023 – https://www.thebusinessresearchcompany.com/report/non-alcoholic-steatohepatitis-nash-global-market-report

Request A Sample Of The Global Non-Alcoholic Steatohepatitis (NASH) Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=8805&type=smp

The Non-Alcoholic Steatohepatitis (NASH) Global Market Report 2023  offers a comprehensive overview on the non-alcoholic steatohepatitis (NASH) market size, growth rate, trends and drivers, opportunities, strategies, and competitor landscape. The countries covered in the non-alcoholic steatohepatitis (NASH) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The Table Of Content For The Non-Alcoholic Steatohepatitis (NASH) Market Include:
1. Non-Alcoholic Steatohepatitis (NASH) Market Executive Summary
2. Non-Alcoholic Steatohepatitis (NASH) Market Segments
3. Non-Alcoholic Steatohepatitis (NASH) Market Size And Non-Alcoholic Steatohepatitis (NASH) Market Growth Rate
4. Key Non-Alcoholic Steatohepatitis (NASH) Market Trends
5. Major Non-Alcoholic Steatohepatitis (NASH) Market Drivers
……
25. Key Mergers And Acquisitions In The Non-Alcoholic Steatohepatitis (NASH) Market
26. Top Non-Alcoholic Steatohepatitis (NASH) Companies
27. Non-Alcoholic Steatohepatitis (NASH) Market Opportunities And Strategies
28. Non-Alcoholic Steatohepatitis (NASH) Market, Conclusions And Recommendations
29. Appendix

View More Related Reports –
Alcoholic – Beverages Global Market Report 2023
Non Alcoholic – Beverages Global Market Report 2023
Ethyl Alcohol And Other Basic Organic Chemical Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model